CAS 59643-91-3

Imexon

Description:

Imexon, with the CAS number 59643-91-3, is a synthetic organic compound primarily recognized for its role as an antineoplastic agent in cancer therapy. It is characterized by its unique chemical structure, which includes a 1,2,4-thiadiazole ring, contributing to its biological activity. Imexon exhibits properties that allow it to induce apoptosis in cancer cells, making it a subject of interest in oncology research. The compound is known to interact with cellular redox systems, leading to oxidative stress that can selectively target malignant cells. Additionally, Imexon has shown potential in enhancing the efficacy of other chemotherapeutic agents. Its solubility and stability in various solvents are important for its formulation in pharmaceutical applications. However, like many therapeutic agents, it may also present side effects, necessitating careful monitoring during treatment. Overall, Imexon represents a promising avenue in the development of targeted cancer therapies, although further studies are essential to fully understand its mechanisms and optimize its clinical use.

Formula: C₄H₅N₃O

InChI: InChI=1S/C4H5N3O/c5-3-2-1-7(2)4(8)6-3/h2H,1H2,(H2,5,6,8)

InChI key: InChIKey=BIXBBIPTYBJTRY-UHFFFAOYSA-N

SMILES: NC=1C2N(C2)C(=O)N1

Synonyms:

• 1,3-Diazabicyclo[3.1.0]hex-3-en-2-one, 4-amino-
• 2-Amino-3,5-diazabicyclo[3.1.0]hex-2-en-4-one
• 4-Amino-1,3-Diazabicyclo[3.1.0]Hex-3-En-2-One
• 4-Imino-1,3-diazabicyclo[3.4.0]hexane-2-one
• Amplimexon
• Bm 06002
• Imexon
• NSC 313425

Imexon

CAS: 59643-91-3

Imexon is an iminopyrrolidone aziridine. It has anti-cancer activity.

Formula: C₄H₅N₃O

Purity: 98%

Color and Shape: Solid

Molecular weight: 111.1

Ref: TM-T15566